Skip to Main Content

Select country

Select your country

Diagnostic Application Notes

The ESR1 Control Kit includes synthetic DNA with clinically relevant ESR1 mutations at 1% VAF and a wild-type control, supporting assay performance and LoD studies. This application note outlines how to create lower-VAF samples using the kit and the cfgDNA Normal Female Standard Background to assess assay sensitivity.

This report summarizes a virtual round table discussion about the future of molecular diagnostics and strategies for deploying them effectively during the next pandemic.

This report summaries a virtual roundtable discussion in which experts discuss the FDA’s LDT rule, the challenges it presents to clinical laboratories, and how IVD vendors can help clinical labs navigate these challenges.

AlertAlertBrowse fileDownload fileFileImagePdfWordTextExcelPowerpointArchiveCsvAudioVideoSpinnerCalendarReturn arrowMinusVisibleInvisibleVisibleInvisibleConfigure